Sponsors

RECENT NEWS

PredxBio and Hamamatsu to deliver next-generation spatial biology solutions

PredxBio, a pioneer in AI-powered spatial biomarker discovery, is to partner with Hamamatsu to deliver next-generation spatial biology solutions for cancer research and therapeutic development.

Partnership to integrate sequencing and analysis platforms

Complete Genomics, a leading innovator in genomic sequencing, has announced a collaboration with Velsera, a leading global healthcare technology company, to deliver an end-to-end genetic testing solution that integrates DNBSEQ sequencing technology with Velsera's Clinical Genomics Workspace (CGW) data analysis solution.

Gestalt Raises $7.5 million to develop AI pathology

Gestalt, a leading innovator in AI-powered digital pathology solutions, has raised $7.5 million Series A financing to further develop its AI-powered pathology platform, PathFlow.

Sophia Genetics and AstraZeneca expand liquid biopsy partnership

Medtech firm Sophia Genetics is to expand its ongoing collaboration with AstraZeneca to accelerate the deployment of MSK-ACCESS liquid biopsy application.

AnalytiChem introduces Redipor ready-to-use culture media globally

AnalytiChem, manufacturer of laboratory equipment, reagents and consumables, has introduced Redipo, a new range of ready-to-use culture media.

NHS Wales to trial AI-assisted pathology

Paige, together with NHS Wales, has announced the launch of a new pilot project at Betsi Cadwaladr University Health Board (BCUHB). The project will evaluate how Paige’s AI-assisted diagnostic application, Paige PanCancer Detect, can streamline pathology workflows and enhance patient care by triaging routine clinical cases.

UKHSA publishes mpox strategy

The UK Health Security Agency (UKHSA), has just published an overarching public health strategy for controlling and eliminating mpox (previously referred to as monkeypox) across the UK, focusing on the next 12-month period.

Novel cancer blood test set for UK clinical trial

In collaboration with the National Institute for Health and Care Research (NIHR), the UK government has awarded £2.4 million to progress the development of a novel AI-driven blood test, known as miONCO-Dx.

New instrument automates density gradient preparation

Beckman Coulter Life Sciences has launched the OptiMATE Gradient Maker, a groundbreaking instrument designed to automate the process of density gradient ultracentrifugation (DGUC).

Integrative approach boosts Alzheimer’s gene research

A new study provides solutions to the pressing need to identify factors that influence Alzheimer’s disease (AD) risk or resistance while providing an avenue to explore potential biological markers and therapeutic targets.

​AMR-related infections caused over 3 million child deaths in 2022

A landmark study presented at ESCMID Global 2025 has revealed that over 3 million children worldwide lost their lives in 2022 due to antimicrobial resistance (AMR)-related infections.

£9 million investment fuels groundbreaking bioscience research

UK Research and Innovation’s Biotechnology and Biological Sciences Research Council (BBSRC) has announced £9 million in funding for a variety of bioscience projects, with its prestigious 2024 Fellowships scheme supporting 19 future science leaders

Roche announces US investment in diagnostics

Roche has announced an investment of US $50 billion into the United States of America in the next five years across its pharmaceutical and diagnostics divisions.

ARUP launches pTau 217 blood test to detect Alzheimer's

ARUP Laboratories now provides a blood test for phosphorylated tau 217 (pTau 217) to assist in identifying whether cognitive decline symptoms in patients ages 60 years and older are related to Alzheimer's disease (AD) pathology.

Partnership to develop AI models for MS

Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, has announced a strategic partnership with the Accelerated Cure Project (ACP), a nonprofit organisation dedicated to accelerating research and improving outcomes for people with multiple sclerosis (MS).

$10 million invested in AI disease detection at University of Pittsburgh

Leidos is committing $10 million to accelerate the use of artificial intelligence for detecting and managing diseases, in collaboration with the University of Pittsburgh's Computational Pathology and AI Center of Excellence (CPACE).

Breakthrough study identifies promising biomarker for early sepsis detection in neonates, children and pregnant women

A pioneering study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including neonates, children and pregnant women. This study is the first to evaluate IL-6’s diagnostic performance in a real-world cohort across all three populations.

3D pathology results in more precise breast cancer treatment

The preliminary results of a research collaboration between JelloX Biotech - a Taiwan-based startup at the forefront of cancer pathology – and the National Taiwan University Hospital (NTUH) on breast cancer patients shows that 3D pathology technology leads to more precise treatment for breast cancer patients.

RDi completes strategic acquisition of Inicio Health

LDC-backed RDi, a leader in data driven, automated self-sampling kits for healthcare, is pleased to announce the successful acquisition of Inicio Health, a pioneering force in healthcare interoperability, automation and AI solutions.

At-home saliva test better than blood test at detecting prostate cancer

A simple at-home saliva test may be more accurate at detecting prostate cancer than the current prostate-specific antigen (PSA) blood test, new National Institute for Health and Care Research (NIHR)-funded research suggests.

Latest Issues

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025

Annual SHOT Symposium

Hilton Birmingham Metropole Hotel, B40 1P
11 July 2025